{"entity":{"type":"insider","cik":"0001268135","url":"/insider/0001268135","json_url":"/insider/0001268135.json","name":"PRZYBYL ARTHUR","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":10,"first":"2006-12-14","last":"2019-05-15","span_basis":"filed_date"},"name_variants":[{"name":"PRZYBYL ARTHUR","source":"filing","n_filings":10,"first_seen":"2006-12-14","last_seen":"2019-05-15"}],"transactions":[{"id":7905647,"accession":"0001144204-19-026662","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-19-026662","line_url":"/filing/0001144204-19-026662#line-3","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14633.0,"shares_display":"14,633","price_per_share":69.25,"price_display":"69.25","price_state":"stated","total_value":1013335.25,"total_display":"1,013,335.25","total_whole":"1,013,335","shares_owned_after":202589.0,"shares_owned_after_display":"202,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-15","filed_date":"2019-05-15","scope":"insider"},{"id":7905645,"accession":"0001144204-19-026662","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-026662","line_url":"/filing/0001144204-19-026662#line-2","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5772.0,"shares_display":"5,772","price_per_share":70.45,"price_display":"70.45","price_state":"stated","total_value":406637.4,"total_display":"406,637.40","total_whole":"406,637","shares_owned_after":217222.0,"shares_owned_after_display":"217,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-14","filed_date":"2019-05-15","scope":"insider"},{"id":7905640,"accession":"0001144204-19-026662","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-026662","line_url":"/filing/0001144204-19-026662#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9595.0,"shares_display":"9,595","price_per_share":71.1,"price_display":"71.10","price_state":"stated","total_value":682204.5,"total_display":"682,204.50","total_whole":"682,205","shares_owned_after":222994.0,"shares_owned_after_display":"222,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-13","filed_date":"2019-05-15","scope":"insider"},{"id":7864568,"accession":"0001144204-19-015117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-015117","line_url":"/filing/0001144204-19-015117#line-2","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2823.0,"shares_display":"2,823","price_per_share":63.51,"price_display":"63.51","price_state":"stated","total_value":179288.73,"total_display":"179,288.73","total_whole":"179,289","shares_owned_after":205076.0,"shares_owned_after_display":"205,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-19","filed_date":"2019-03-20","scope":"insider"},{"id":7864567,"accession":"0001144204-19-015117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-015117","line_url":"/filing/0001144204-19-015117#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24802.0,"shares_display":"24,802","price_per_share":63.53,"price_display":"63.53","price_state":"stated","total_value":1575671.06,"total_display":"1,575,671.06","total_whole":"1,575,671","shares_owned_after":205076.0,"shares_owned_after_display":"205,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-20","scope":"insider"},{"id":6511807,"accession":"0001144204-18-014729","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-18-014729","line_url":"/filing/0001144204-18-014729#line-4","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":62.03,"price_display":"62.03","price_state":"stated","total_value":620300.0,"total_display":"620,300.00","total_whole":"620,300","shares_owned_after":185706.0,"shares_owned_after_display":"185,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-14","filed_date":"2018-03-14","scope":"insider"},{"id":6511806,"accession":"0001144204-18-014729","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-18-014729","line_url":"/filing/0001144204-18-014729","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":61.761425,"price_display":"61.76","price_state":"stated","total_value":1852842.75,"total_display":"1,852,842.75","total_whole":"1,852,843","shares_owned_after":202231.0,"shares_owned_after_display":"202,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-13","filed_date":"2018-03-14","scope":"insider","n_lines":2},{"id":6687432,"accession":"0001144204-18-012823","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-18-012823","line_url":"/filing/0001144204-18-012823","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23986.0,"shares_display":"23,986","price_per_share":61.23132410572834,"price_display":"61.23","price_state":"stated","total_value":1468694.54,"total_display":"1,468,694.54","total_whole":"1,468,695","shares_owned_after":222643.0,"shares_owned_after_display":"222,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-05","scope":"insider","n_lines":3},{"id":3250302,"accession":"0001144204-16-120761","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-16-120761","line_url":"/filing/0001144204-16-120761#line-4","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37455.0,"shares_display":"37,455","price_per_share":66.97,"price_display":"66.97","price_state":"stated","total_value":2508361.35,"total_display":"2,508,361.35","total_whole":"2,508,361","shares_owned_after":191806.0,"shares_owned_after_display":"191,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-22","filed_date":"2016-08-23","scope":"insider"},{"id":8683539,"accession":"0001144204-15-064775","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-064775","line_url":"/filing/0001144204-15-064775#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":40.95,"price_display":"40.95","price_state":"stated","total_value":102375.0,"total_display":"102,375.00","total_whole":"102,375","shares_owned_after":145195.0,"shares_owned_after_display":"145,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-12","filed_date":"2015-11-12","scope":"insider"},{"id":8608825,"accession":"0001144204-15-016482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-016482","line_url":"/filing/0001144204-15-016482#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":63.0,"price_display":"63.00","price_state":"stated","total_value":4725000.0,"total_display":"4,725,000.00","total_whole":"4,725,000","shares_owned_after":114164.0,"shares_owned_after_display":"114,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-12","filed_date":"2015-03-16","scope":"insider"},{"id":6606733,"accession":"0001144204-14-055078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-055078","line_url":"/filing/0001144204-14-055078#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":26.5,"price_display":"26.50","price_state":"stated","total_value":26500.0,"total_display":"26,500.00","total_whole":"26,500","shares_owned_after":189162.0,"shares_owned_after_display":"189,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-09","filed_date":"2014-09-09","scope":"insider"},{"id":3324211,"accession":"0001209191-08-038713","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-038713","line_url":"/filing/0001209191-08-038713#line-2","is_derivative":false,"issuer_cik":"0000003116","issuer_name":"AKORN INC","issuer_ticker":"AKRX","issuer_name_source":null,"issuer_url":"/issuer/0000003116","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21152.0,"shares_display":"21,152","price_per_share":3.3265,"price_display":"3.33","price_state":"stated","total_value":70362.128,"total_display":"70,362.13","total_whole":"70,362","shares_owned_after":222740.0,"shares_owned_after_display":"222,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-23","filed_date":"2008-06-24","scope":"insider"},{"id":3324207,"accession":"0001209191-08-038713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-038713","line_url":"/filing/0001209191-08-038713#line-1","is_derivative":false,"issuer_cik":"0000003116","issuer_name":"AKORN INC","issuer_ticker":"AKRX","issuer_name_source":null,"issuer_url":"/issuer/0000003116","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":251850.0,"shares_display":"251,850","price_per_share":3.4141,"price_display":"3.41","price_state":"stated","total_value":859841.085,"total_display":"859,841.08","total_whole":"859,841","shares_owned_after":243892.0,"shares_owned_after_display":"243,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-20","filed_date":"2008-06-24","scope":"insider"},{"id":5476029,"accession":"0001209191-06-064886","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-06-064886","line_url":"/filing/0001209191-06-064886#line-3","is_derivative":false,"issuer_cik":"0000003116","issuer_name":"AKORN INC","issuer_ticker":"AKN","issuer_name_source":null,"issuer_url":"/issuer/0000003116","owner_cik":"0001268135","owner_name":"PRZYBYL ARTHUR","owner_display_name":"PRZYBYL ARTHUR","owner_url":"/insider/0001268135","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":485335.0,"shares_owned_after_display":"485,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-12","filed_date":"2006-12-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001023024","name":"ANI PHARMACEUTICALS INC","url":"/issuer/0001023024","role":"Director, Officer (President and CEO)","n_filings":8,"first_seen":"2014-09-09","last_seen":"2019-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000003116","name":"AKORN INC","url":"/issuer/0000003116","role":"Director, Officer (President, CEO)","n_filings":2,"first_seen":"2006-12-14","last_seen":"2008-06-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001268135","retrieved_at":"2026-08-24T16:15:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}